Akèy › Distrofi Miskilè Duchenne › Tennessee
Etid klinik pou Distrofi Miskilè Duchenne nan Tennessee
4 etid pou Distrofi Miskilè Duchenne ap chèche patisipan nan sit nan Tennessee.
Vil nan Tennessee
Tèks ofisyèl etid la (Anglè)
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1
Laj 8 a 18 · Gason · Mizajou Aug 24, 2026 · NCT07172971Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 28, 2026 · NCT07674758Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
- Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 10 ak plis · Gason · Mizajou May 22, 2026 · NCT06124196Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
- Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Laj 10 ak plis · Gason · Mizajou Nov 6, 2025 · NCT06093100Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.